Woodcliff Lake, NJ - May 7, 2008 - Eisai Corporation of North America and its U.S. subsidiary, MGI PHARMA, INC., today announced that the U.S. Food and Drug Administration (FDA) Advisory Committee on ...
Eisai Corp. has announced that the FDA has approved its Lusedra (fospropofol disodium) Injection, an intravenous sedative-hypnotic agent for monitored anesthesia care sedation. The injection is for ...
WOODCLIFF LAKE, N.J., Dec. 14 /PRNewswire/ -- Eisai Corporation of North America today announced that the U.S. Food and Drug Administration (FDA) has approved LUSEDRA(TM) (fospropofol disodium) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback